Upstream Bio Insider Selling Surge: Impact on Stock, Pipeline, & Investor Outlook
Upstream Bio insiders sell 4,600+ shares to cover RSUs, yet the stock stays flat. Learn how these routine trades affect valuation, pipeline prospects, and investor vigilance.
4 minutes to read